On March 4, Glonghui reported that Hualü Biotechnology (300970.SZ) announced that as of the date of disclosure of this announcement, the share repurchase period has expired, and the company's share repurchase plan has been completed. As of the date of disclosure of this announcement, the company repurchased 2,346,600 shares through the Shenzhen Securities Exchange's stock trading system via centralized bidding, accounting for 1.95% of the company's current total share capital, with a highest Fill Price of 13.83 yuan/share, a lowest Fill Price of 12.22 yuan/share, and a total amount of 30.0046 million yuan (excluding transaction fees).
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
Charlie Munger: How to face the significant drawdowns in investments?
Futu Daily | The storm of Trump's tariffs is coming! On April 2, the Global financial markets may face "turbulent waves;" the Treasury makes a significant move, injecting 500 billion into the four major state-owned banks.
Gold has skyrocketed past $3,100! Q&M Dental is "crazy" about purchasing, how long can this trend last?
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
华绿生物(300970.SZ):回购完成 已累计回购1.95%股份
Hualü Biological (300970.SZ): Buyback completed, having repurchased a total of 1.95% of shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 235
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report